• Senesco Technologies Inc., of Bridgewater, N.J., entered into a securities purchase agreement to raise $2 million through the sale of 7.69 million shares of common stock. Outside investors also will receive 50 percent warrant coverage at an exercise price of $0.286 per share. Each unit was priced at 26 cents each. Net proceeds are expected to cover working capital and research and development as well as general corporate purposes. The company is developing SNS01-T in multiple myeloma and other B-cell cancers.